| Application no. and date | 14705908.3 (espacenet) (Federated) (European Patent Register), 20140131 | | Patent/reg. no. and date | DK/EP 2950795, 20180425 | | Publication date | 20151209 | | Priority no. and date | US 201361758918 P, 20130131 | | EP pub. no. and date |
EP 2950795 20151209 | | Effective date | | | Applicant/owner | Boehringer Ingelheim Animal Health USA Inc., 3239 Satellite Boulevard, Bldg. 500
Duluth, GA 30096, US | | Applicant ref. no. | P64673DK01 | | Inventor | POLLMEIER, Matthias, Haus-Endt-Str. 48
40593 Düsseldorf, FR,
BLAIR, Jeffrey, Jynn, 236 avenue Thiers
33100 Bordeaux, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4164 (2006.01) , A61P 33/02 (2006.01) | | Title | FREMGANGSMÅDE TIL BEHANDLING OG HELING AF LEISHMANIOSE UNDER ANVENDELSE AF FEXINIDAZOL | | Int. application no. | US2014014134 | | Int. publication no. | WO2014121064 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
